Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MSI-H/dMMR + BRAF Mutation
i
Other names:
MSI | Microsatellite instability, BRAF, B-raf proto-oncogene, B-raf proto-oncogene, Serine/threonine kinase, V-Raf murine sarcoma viral oncogene homolog B, Serine/threonine-protein kinase B-Raf, Proto-oncogene B-Raf, BRAF1, RAFB1, B-raf proto-oncogene Serine/threonine-protein kinase, Murine sarcoma viral (V-Raf) oncogene homolog B1, B-raf serine/threonine-protein, 94 KDa B-raf protein, B-RAF1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
673
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
MSI-H/dMMR (182)
HER-2 amplification + RAS wild-type + BRAF wild-type (9)
MSI-H/dMMR + TMB-H (8)
MSI-L/dMMR (6)
MSI-H/dMMR + TMB-L (5)
PTEN mutation + MSI-H/dMMR (5)
MSI-H/dMMR + POLE mutation (4)
BRAF V600K + LDH elevation (3)
ARID1A mutation + MSI-H (3)
MSI-H/dMMR + MLH1 deletion + PMS2 deletion (3)
MSI-H/dMMR + TMB-H + PD-L1 negative (3)
BRAF V600E + MSI-H (2)
BRAF V600E + PD-L1 expression (2)
BRAF V600E + PD-L1 expression (2)
BRAF V600E + PIK3CA mutation + SMAD4 mutation + MSI-H/dMMR (2)
BRAF V600E + ROS1 fusion (2)
BRAF mutation + MET amplification (2)
BRAF mutation + MSI-L/dMMR (2)
BRAF mutation + TERT overexpression (2)
BRAF wild-type + HER-2 positive (2)
EZR overexpression + BRAF V600E (2)
IDH1 mutation + BRAF V600E (2)
IDH1 mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (2)
IDH2 mutation + BRAF V600E (2)
IDH2 mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (2)
MSI-H/dMMR + BRAF V600E (2)
PD-L1 expression + NRAS Q61R + BRAF D594N (2)
PD-L1 overexpression + BRAF V600E (2)
RAS wild-type + BRAF wild-type + HER-2 positive (2)
MSI-H/dMMR + TMB-H + PD-L1 overexpression (2)
MSI-L/dMMR + KRAS G12V (2)
ALK fusion + EGFR exon 19 deletion + BRAF G466V + MAP2K1 F129L (1)
ALK rearrangement + ALK I1171N + ALK V1180L + BRCA2 F2801fs (1)
BRAF E501Q + PD-L1 negative (1)
BRAF V600 + LDH elevation (1)
BRAF V600 + LDH elevation + PD-L1 negative (1)
BRAF V600E + CDKN2A deletion + MYCN amplification (1)
BRAF V600E + CDKN2A deletion + RB1 expression (1)
BRAF V600E + EGFR expression (1)
BRAF V600E + PTEN deletion (1)
BRAF V600E + SOX2 amplification (1)
BRAF V600K + CDKN2A deletion + RB1 expression (1)
BRAF mutation + PD-L1 overexpression (1)
BRAF mutation + TMB-H (1)
BRAF mutation + TMB-L + MSI-L/dMMR (1)
BRAF negative + GKAP1-NTRK2 exon 10-16 in-frame fusion (1)
BRAF wild-type + HGF elevation (1)
CD8 elevation + BRAF V600 (1)
Chr t(11;14) + BRAF mutation (1)
EGFR exon 19 deletion + BRAF G464A (1)
EGFR overexpression + BRAF V600E (1)
EGFR overexpression + BRAF mutation (1)
HER-2 amplification + BRAF wild-type (1)
HR positive + BRAF V600E (1)
KIAA1549-BRAF fusion + MET amplification (1)
KIAA1549-BRAF fusion + PTEN deletion (1)
KRAS wild-type + BRAF V600E (1)
LDH elevation + BRAF mutation (1)
MAP2K1 mutation + BRAF wild-type (1)
MSI-H/dMMR + KRAS wild-type + BRAF wild-type (1)
NRAS mutation + BRAF wild-type (1)
PD-L1 expression + BRAF negative (1)
PIK3CA mutation + BRAF wild-type (1)
SEMA6A overexpression + BRAF mutation (1)
SRC overexpression + BRAF V600E (1)
TNFAIP3 overexpression + BRAF mutation (1)
B2M mutation + MSI-H/dMMR (1)
ER positive + MLH1 1835del3 + MSI-H/dMMR + TMB-H (1)
JAK1 mutation + MSI-H/dMMR (1)
JAK2 mutation + MSI-H/dMMR (1)
KRAS wild-type + NRAS wild-type + MSI-H/dMMR (1)
MLH1 methylation + MSI-H/dMMR (1)
MLH1 methylation + MSI-H/dMMR + TMB-H (1)
MSH6 mutation + MLH1 mutation + MSI-H (1)
MSI-H + HER-2 amplification (1)
MSI-H + MSH2 expression + MSH6 expression (1)
MSI-H/dMMR + HER-2 mutation (1)
MSI-H/dMMR + KDR overexpression (1)
MSI-H/dMMR + KRAS Mutation (1)
MSI-H/dMMR + MLH1 negative + PMS2 negative (1)
MSI-H/dMMR + NTRK1 fusion (1)
MSI-H/dMMR + NTRK2 fusion (1)
MSI-H/dMMR + NTRK3 fusion (1)
MSI-H/dMMR + PD-1 expression + CD8 positive (1)
MSI-H/dMMR + RAS mutation (1)
MSI-H/dMMR + TP53 mutation (1)
NOTCH1 mutation + TMB-L + MSI-L/dMMR (1)
PD-L1 expression + MSI-H/dMMR (1)
PIK3CA E542Q + TMB-H + MSI-H/dMMR (1)
SMARCA4 deletion + dMMR/MSI-H + PD-L1 underexpression (1)
TMB-H + PD-L1 expression + MSI-L/dMMR (1)
PD-L1 overexpression + BRAF mutation (0)
AKT1 E17K + CTNNB1 G34R + ER Y537S + MSI-H (0)
MSI-H/dMMR + RAS wild-type (0)
MSI-L/dMMR + SMAD4 mutation (0)
PIK3CA mutation + TMB-L + MSI-L/dMMR (0)
MSI-H/dMMR (182)
HER-2 amplification + RAS wild-type + BRAF wild-type (9)
MSI-H/dMMR + TMB-H (8)
MSI-L/dMMR (6)
MSI-H/dMMR + TMB-L (5)
PTEN mutation + MSI-H/dMMR (5)
MSI-H/dMMR + POLE mutation (4)
BRAF V600K + LDH elevation (3)
ARID1A mutation + MSI-H (3)
MSI-H/dMMR + MLH1 deletion + PMS2 deletion (3)
MSI-H/dMMR + TMB-H + PD-L1 negative (3)
BRAF V600E + MSI-H (2)
BRAF V600E + PD-L1 expression (2)
BRAF V600E + PD-L1 expression (2)
BRAF V600E + PIK3CA mutation + SMAD4 mutation + MSI-H/dMMR (2)
BRAF V600E + ROS1 fusion (2)
BRAF mutation + MET amplification (2)
BRAF mutation + MSI-L/dMMR (2)
BRAF mutation + TERT overexpression (2)
BRAF wild-type + HER-2 positive (2)
EZR overexpression + BRAF V600E (2)
IDH1 mutation + BRAF V600E (2)
IDH1 mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (2)
IDH2 mutation + BRAF V600E (2)
IDH2 mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (2)
MSI-H/dMMR + BRAF V600E (2)
PD-L1 expression + NRAS Q61R + BRAF D594N (2)
PD-L1 overexpression + BRAF V600E (2)
RAS wild-type + BRAF wild-type + HER-2 positive (2)
MSI-H/dMMR + TMB-H + PD-L1 overexpression (2)
MSI-L/dMMR + KRAS G12V (2)
ALK fusion + EGFR exon 19 deletion + BRAF G466V + MAP2K1 F129L (1)
ALK rearrangement + ALK I1171N + ALK V1180L + BRCA2 F2801fs (1)
BRAF E501Q + PD-L1 negative (1)
BRAF V600 + LDH elevation (1)
BRAF V600 + LDH elevation + PD-L1 negative (1)
BRAF V600E + CDKN2A deletion + MYCN amplification (1)
BRAF V600E + CDKN2A deletion + RB1 expression (1)
BRAF V600E + EGFR expression (1)
BRAF V600E + PTEN deletion (1)
BRAF V600E + SOX2 amplification (1)
BRAF V600K + CDKN2A deletion + RB1 expression (1)
BRAF mutation + PD-L1 overexpression (1)
BRAF mutation + TMB-H (1)
BRAF mutation + TMB-L + MSI-L/dMMR (1)
BRAF negative + GKAP1-NTRK2 exon 10-16 in-frame fusion (1)
BRAF wild-type + HGF elevation (1)
CD8 elevation + BRAF V600 (1)
Chr t(11;14) + BRAF mutation (1)
EGFR exon 19 deletion + BRAF G464A (1)
EGFR overexpression + BRAF V600E (1)
EGFR overexpression + BRAF mutation (1)
HER-2 amplification + BRAF wild-type (1)
HR positive + BRAF V600E (1)
KIAA1549-BRAF fusion + MET amplification (1)
KIAA1549-BRAF fusion + PTEN deletion (1)
KRAS wild-type + BRAF V600E (1)
LDH elevation + BRAF mutation (1)
MAP2K1 mutation + BRAF wild-type (1)
MSI-H/dMMR + KRAS wild-type + BRAF wild-type (1)
NRAS mutation + BRAF wild-type (1)
PD-L1 expression + BRAF negative (1)
PIK3CA mutation + BRAF wild-type (1)
SEMA6A overexpression + BRAF mutation (1)
SRC overexpression + BRAF V600E (1)
TNFAIP3 overexpression + BRAF mutation (1)
B2M mutation + MSI-H/dMMR (1)
ER positive + MLH1 1835del3 + MSI-H/dMMR + TMB-H (1)
JAK1 mutation + MSI-H/dMMR (1)
JAK2 mutation + MSI-H/dMMR (1)
KRAS wild-type + NRAS wild-type + MSI-H/dMMR (1)
MLH1 methylation + MSI-H/dMMR (1)
MLH1 methylation + MSI-H/dMMR + TMB-H (1)
MSH6 mutation + MLH1 mutation + MSI-H (1)
MSI-H + HER-2 amplification (1)
MSI-H + MSH2 expression + MSH6 expression (1)
MSI-H/dMMR + HER-2 mutation (1)
MSI-H/dMMR + KDR overexpression (1)
MSI-H/dMMR + KRAS Mutation (1)
MSI-H/dMMR + MLH1 negative + PMS2 negative (1)
MSI-H/dMMR + NTRK1 fusion (1)
MSI-H/dMMR + NTRK2 fusion (1)
MSI-H/dMMR + NTRK3 fusion (1)
MSI-H/dMMR + PD-1 expression + CD8 positive (1)
MSI-H/dMMR + RAS mutation (1)
MSI-H/dMMR + TP53 mutation (1)
NOTCH1 mutation + TMB-L + MSI-L/dMMR (1)
PD-L1 expression + MSI-H/dMMR (1)
PIK3CA E542Q + TMB-H + MSI-H/dMMR (1)
SMARCA4 deletion + dMMR/MSI-H + PD-L1 underexpression (1)
TMB-H + PD-L1 expression + MSI-L/dMMR (1)
PD-L1 overexpression + BRAF mutation (0)
AKT1 E17K + CTNNB1 G34R + ER Y537S + MSI-H (0)
MSI-H/dMMR + RAS wild-type (0)
MSI-L/dMMR + SMAD4 mutation (0)
PIK3CA mutation + TMB-L + MSI-L/dMMR (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MSI-H/dMMR + BRAF Mutation
Colorectal Cancer
MSI-H/dMMR + BRAF Mutation
Colorectal Cancer
nivolumab + ipilimumab
Sensitive: C3 – Early Trials
nivolumab + ipilimumab
Sensitive
:
C3
nivolumab + ipilimumab
Sensitive: C3 – Early Trials
nivolumab + ipilimumab
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.